🔎 Trials Near Me

Početna › Wilmsov tumor › Tennessee

Kliničke studije za Wilmsov tumor u državi Tennessee

6 studija za Wilmsov tumor traži sudionike na lokacijama u državi Tennessee.

Gradovi u državi Tennessee

Službeni tekst studije (engleski)

Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor

  • Saint Jude Children's Research Hospital, Memphis
U tijeku regrutacijaFaza 2
Od 12 do 39 godina · Oba spola · Ažurirano 29. ruj 2026. · NCT04616560

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

  • East Tennessee Childrens Hospital, Knoxville
  • Saint Jude Children's Research Hospital, Memphis
  • The Children's Hospital at TriStar Centennial, Nashville
  • i još 1
U tijeku regrutacijaFaza 2
Do 30 godina · Oba spola · Ažurirano 25. kol 2026. · NCT04322318

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • Saint Jude Children's Research Hospital, Memphis
U tijeku regrutacijaFaza 1/2
12 Months – 30 Years · Oba spola · Ažurirano 25. kol 2026. · NCT04851119

B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)

  • St. Jude Children's Research Hospital, Memphis
U tijeku regrutacijaFaza 1
Do 21 godina · Oba spola · Ažurirano 19. svi 2026. · NCT04897321

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

  • St. Jude Children's Research Hospital, Memphis
U tijeku regrutacijaFaza 1/2
12 Months – 30 Years · Oba spola · Ažurirano 19. svi 2026. · NCT04901702

Treatment of Newly Diagnosed Patient's With Wilm's Tumor Requiring Abdominal Radiation Delivered With Proton Beam Irradiation

  • St.Jude Children's Research Hospital, Memphis
U tijeku regrutacijaFaza 2
Sve dobne skupine · Oba spola · Ažurirano 23. tra 2026. · NCT04968990

Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.